PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS
https://doi.org/10.15829/1560-4071-2016-12-39-44
Abstract
Aim. To study the influence of various geometric models of the left ventricle (LV) on long-term prognosis in arterial hypertension (AH).
Material and methods. Totally, 180 AH patients studied at the age 50,5±6,7 y.o., for 10 years of follow-up. All patients at the inclusion stage underwent standard clinical and functional investigation, 2D-echocardiography, 6-minute walking test, NT-proBNP.
Results. By EchoCG theLV hypertrophy (LVH) was found 1,8 times more frequently than by ECG. Normal geometry of theLV was found in 25,5%, concentric LVH — 42,8%, eccentric LVH — 11,7%.
Conclusion. By the multifactorial analysis, LVH was independent predictor of adverse prognosis and, in combination with other independent factors (age, male gender, 6-minute walking test, NT-proBNP level in plasma) did double the probability of an adverse cardiovascular risk.
About the Authors
S. V. Ivanova
A. I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Yu. A. Vasyuk
A. I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
E. L. Shkolnik
A. I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
A. V. Khadzegova
A. I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
I. A. Sinitsina
A. I. Evdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
References
1. Devereux RB, Wachtell K, Gerdts E, et al. Prognostic of left ventricular mass change during treatment of hypertension. JAMA. 2004; 292(19): 2350-6.
2. Pewsner D, Juni P, Egger M, et al. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007; 335 (7662): 711.
3. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2013; 34, 2159-219 doi:10.1093/eurheartj/eht151
4. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. Eur J Echocardiography, 2006; 7: 79-108.
5. Drapkina OM, Eliashevich SO, Shepel RN. Obesity is a risk factor for chronic noncommunicable diseases. Russian Journal of Cardiology. 2016; 6: 73-9. Russian (Драпкина О. М., Елиашевич С. О., Шепель Р. Н. Ожирение как фактор риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2016; 6: 73-9).
6. Puterbaugh JS.Reducing societal obesity: establishing a separate exercise model through studies of group behavior. J Obes. 2016; 2016: 6734043. Published online 2016 Jun 27. doi: 10.1155/2016/6734043
7. Goncharova LN, Biryukova DV, Kuzovenkova ON, et al. Predictors of CHF in patients with arterial hypertension among the indigenous population of the Republic of Mordovia. Journal of Heart Failure. 2009; 10 (1): 26-7. Russian (Гончарова Л.Н, Бирюкова Д. В., Кузовенкова О. Н. и др. Предикторы развития ХСН у больных артериальной гипертонией среди коренного населения Республики Мордовия. Журнал Сердечная недостаточность. 2009; 10 (1): 26-7).
8. Oganov RG, Timofeeva TN, Koltunov IE, et al. Arterial hypertension epidemiology in Russia. The results of 2003-2010 Federal monitoring. Cardiovascular Therapy and Prevention 2011; 10(1):9-13. Russian (Оганов Р.Г., Тимофеева Т.Н., Колтунов И. Е. и др. Эпидемиология артериальной гипертонии в России. Результаты федерального мониторинга 2003-2010 гг. Кардиоваскулярная терапия и профилактика 2011; 10 (1): 9-13).
9. Shalnova SA, Balanova YA, Konstantinov VV, et al. Arterial hypertension: prevalence, awareness, antihypertensive pharmaceutical treatment, treatment effectiveness in Russian population. Russ J Cardiol. 2006; 4: 45-50. Russian (Шальнова С.А., Баланова Ю. А., Константинов В. В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал. 2006; 4: 45-50).
10. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 2015, 28, 1: 1-85 http://dx.doi.org/10.1016/j. echo.2014.10.003
11. Glezer MG, Saygitov RT, Prourzina NL. Electrocardiographic signs of left ventricle hypertrophy in women with arterial hypertension. Results of AFINA study. Problems of women health. 2010; 5 (1): 5-15. Russian (Глезер М. Г., Сайгитов Р. Т., Проурзина Н. Л. Электрокардиографические признаки гипертрофии левого желудочка женщин с артериальной гипертензией. Результаты исследования АФИНА. Проблемы женского здоровья. 2010; 5 (1): 5-15).
Review
For citations:
Ivanova S.V., Vasyuk Yu.A., Shkolnik E.L., Khadzegova A.V., Sinitsina I.A. PREDICTION ROLE OF THE LEFT VENTRICLE REMODELLING IN ARTERIAL HYPERTENSION PATIENTS. Russian Journal of Cardiology. 2016;(12):39-44. (In Russ.) https://doi.org/10.15829/1560-4071-2016-12-39-44
Views:
708
Email this article 